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Abstract
Background: Studies have shown an association between smoking and tuberculosis (TB)
infection, disease and TB-related mortality. We hypothesized that smokers with latent tuberculosis
infection (LTBI) are less likely to comply with their LTBI treatment regimen, thus increasing their
risk of developing active disease. We thus documented the impact of smoking on adherence to
LTBI treatment.
Method: Between 1998 and 2000, a convenience sample of patients undergoing treatment for
LTBI completed a questionnaire on smoking status. Level of adherence to LTBI treatment was
tested for associations with socio-demographic profile, and smoking status
Results: 320 patients were recruited, and 302 (94%) completed the questionnaire. Smoking
prevalence was 21%. 72% of patients were adherent to LTBI treatment. Women (OR = 2.0; 95%
CI: 1.2–3.3) and non-smokers (OR = 1.8; 95% CI: 1.0–3.3) were associated with adherence to LTBI
treatment. Only gender was found as an independent predictor of adherence after adjusting for age
and smoking status (OR = 1.9; 95% CI: 1.06–3.3).
Conclusion: Males and smokers need to have extra supervision to ensure compliance with LTBI
treatment.
Background
Studies have shown an association between smoking and
tuberculosis (TB) infection,[1] disease, [2-6] and TB-
related mortality. [7] Based on the premise that smokers
tend to be less compliant to medication [8,9] we hypoth-
esized that smokers with latent tuberculosis infection
(LTBI) are less likely to comply with their LTBI treatment
regimen, thus increasing their risk of developing active
disease. We thus set out to document the impact of smok-
ing on adherence to LTBI.
Methods
For the 1998–2000 period, a convenience sample was
taken of consecutive patients initiating treatment for LTBI
who were given the opportunity to undergo a self-admin-
istered questionnaire (French-English) on baseline demo-
graphic characteristics. Patients were recruited at a
specialized TB clinic located at the Montreal Chest Insti-
tute (MCI), which deals mainly but not exclusively with
new adult immigrants and refugee claimants for whom
immigration screening evaluation suggested inactive TB.
[10] Eligibility of patients was defined according to their
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written informed consent to participate in the study was
obtained before administration of the questionnaire.
Smoking status and nicotine dependence was assessed by
the nurse clinician. We used the Canadian tobacco use
monitoring survey (CTUMS) terminology to define cur-
rent and non- and ex- smokers. [11] Nicotine dependence
in smokers was assessed using a 10 point visual scale, with
1 denoting minimum dependence and 10 denoting max-
imum, using a modified Fagerström test for nicotine
dependence. [12] Subjects were classified as nicotine
dependent if the score was 6 or higher.
The medical evaluation followed the Canadian Thoracic
Society Guidelines for tuberculosis control [13] and
included sputum smear and cultures when indicated.
Adherence to therapy was assessed by the clinic nurses
through pill counts, patient self-report and general attend-
ance at the scheduled medical visits. Adherence was con-
sidered adequate if patients took more than 80% of total
prescribed doses for the LTBI treatment regimen, with the
remainder being considered non adherent.
Level of adherence to LTBI treatment was tested for asso-
ciations with socio-demographic profile (age, gender,
region of birth), and smoking status (current/non- and ex-
smokers). Univariate analysis using chi-square test,
Fisher's exact test or t-test was used to compare various
characteristics of interest to LTBI treatment adherence.
Significance was defined at the p <= 0.05 level. We per-
formed a multiple logistic regression analysis using a step-
wise approach to estimate the independent contribution
of significant characteristics found in the univariate anal-
ysis towards adherence to LTBI. Data analysis was done
using the SAS program (version 8.2). Ethical approval was
obtained from the Montreal Chest Institute ethics com-
mittee.
Results
337 patients were initially asked to participate and 320
were recruited (180 males) with a mean age of 35.5 (SD ±
10.8) years old. We obtained adherence status in 302/320
(94%) participants. More than 87% (281/320) of our
study group was found to be foreign born and 64% of the
latter had immigrated to Canada within the previous 5
years. Most of our participants (33%) came from the
Indian sub continent (mostly India and Pakistan) and
17% from North Africa (mostly Algeria and Morocco).
Smoking prevalence was 21% (28% and 20% among
Canadian born and foreign born respectively). The overall
mean nicotine dependence among smokers was low (2.9/
10 (SD ± 2.4); median 3.0) and reflected the fact that only
17% of current smokers reported being tobacco depend-
ent (Table). Smokers smoked in general less than 12 ciga-
rettes per day (48%), while 23% smoked at least 25
cigarettes a day (the equivalent of a half pack and a full
pack of cigarettes respectively). Overall, adequate adher-
ence to LTBI treatment was found in 217/302 (72%) par-
ticipants. In the univariate analysis, factors associated
with adherence to LTBI treatment included being female
(odds ratio (OR) = 2.0; 95% confidence interval (CI): 1.2–
3.3) and being a non-smoker (OR = 1.8; 95% CI: 1.0–
3.3). Characteristics such as age, region of birth, and nic-
otine dependence among smokers were not associated
with adherence to LTBI (Table). In the multiple logistic
regression analysis, only being female (OR = 1.9; 95% CI:
1.1–3.3) was independently associated with adherence
when adjusted for age and smoking status.
Discussion
In this study, smoking prevalence was found among 21%
of our study population and was more prevalent in men
(33%) than in women (6%). Our finding is comparable
to the prevalence found in the respective region of birth of
the participants. [14] As 88% of our study group were
from the developing world, it was not surprising to see
that men were more likely to smoke than woman. [15,16]
Adequate adherence to LTBI was found in 72% of patients
and is consistent with previous studies done at the MCI.
[10] In our univariate analysis, men and smokers were less
likely to be compliant to treatment. The multiple logistic
regression analysis showed that gender was the only inde-
pendent predictor of adherence. Males may be less com-
pliant to LTBI treatment for economic reasons. In various
cultures, men are the main contributors to the family
income and cannot afford to take time out for a medical
visit to a clinic. Indeed, travel time to and from the clinic
represents time absent from work and potentially less
money earned. [17] This speculation is supported by the
finding among our study group that men were less likely
than women to report attending regular medical visits (p
< 0.001). Another plausible reason would be that males
are less likely to adhere to healthy behaviours and preven-
tion messages such as smoking cessation and adherence to
treatment.
Certain limitations in this study have to be recognized.
The self-report of smoking status could have been biased
by a certain degree of social desirability from the respond-
ent which may have underestimated the true prevalence of
smoking. Characteristics such as economic status and lan-
guage barriers/comprehension (although the latter was
initially addressed in the participant selection) might have
also influenced adherence, especially in the foreign-born,
but were not sought after in this study. Our convenience
sample of participants was nonetheless representative of
the overall MCI clinic attendance with respect to basic
socio-demographic factors,[18,19] although generaliza-Page 2 of 4
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limited. We also had a small proportion (5%) of eligible
subjects who refused to participate. We were not able to
characterize these individuals but there is no reason to
think that they were any different from our study group
regarding the variables of interest.
Conclusion
Overall, our findings indicate that males and smokers
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